Journey Medical (DERM) Short term Debt: 2021-2025
Historic Short term Debt for Journey Medical (DERM) over the last 1 years, with Sep 2025 value amounting to $5.6 million.
- Journey Medical's Short term Debt was N/A to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2022, which is 263.05% up from last year.
- Latest data reveals that Journey Medical reported Short term Debt of $5.6 million as of Q3 2025, which was up 50.00% from $3.8 million recorded in Q2 2025.
- Journey Medical's 5-year Short term Debt high stood at $9.9 million for Q2 2023, and its period low was $812,000 during Q4 2021.
- Moreover, its 2-year median value for Short term Debt was $5.6 million (2025), whereas its average is $6.2 million.
- Data for Journey Medical's Short term Debt shows a peak YoY skyrocketed of 263.05% (in 2022) over the last 5 years.
- Journey Medical's Short term Debt (Quarterly) stood at $812,000 in 2021, then surged by 263.05% to $2.9 million in 2022, then reached $9.9 million in 2023, then reached $5.6 million in 2025.
- Its Short term Debt stands at $5.6 million for Q3 2025, versus $3.8 million for Q2 2025 and $1.9 million for Q1 2025.